BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25039645)

  • 1. Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study.
    Folsom AR; Roetker NS; Rosamond WD; Heckbert SR; Basu S; Cushman M; Lutsey PL
    J Thromb Haemost; 2014 Sep; 12(9):1455-60. PubMed ID: 25039645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies.
    Bell EJ; Agarwal SK; Cushman M; Heckbert SR; Lutsey PL; Folsom AR
    Am J Hypertens; 2016 May; 29(5):634-40. PubMed ID: 26306405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study.
    Lutsey PL; Michos ED; Misialek JR; Pankow JS; Loehr L; Selvin E; Reis JP; Gross M; Eckfeldt JH; Folsom AR
    JACC Heart Fail; 2015 May; 3(5):347-356. PubMed ID: 25863973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.
    Folsom AR; Alonso A; George KM; Roetker NS; Tang W; Cushman M
    Thromb Res; 2015 Oct; 136(4):781-5. PubMed ID: 26337932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: The ARIC study.
    Michos ED; Misialek JR; Selvin E; Folsom AR; Pankow JS; Post WS; Lutsey PL
    Atherosclerosis; 2015 Jul; 241(1):12-7. PubMed ID: 25941991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort.
    Rapson IR; Michos ED; Alonso A; Hirsch AT; Matsushita K; Reis JP; Lutsey PL
    Atherosclerosis; 2017 Feb; 257():123-129. PubMed ID: 28131046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study.
    Schneider AL; Lutsey PL; Selvin E; Mosley TH; Sharrett AR; Carson KA; Post WS; Pankow JS; Folsom AR; Gottesman RF; Michos ED
    Eur J Neurol; 2015 Aug; 22(8):1220-7. PubMed ID: 25962507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of sickle cell trait and venous thromboembolism incidence.
    Folsom AR; Tang W; Roetker NS; Kshirsagar AV; Derebail VK; Lutsey PL; Naik R; Pankow JS; Grove ML; Basu S; Key NS; Cushman M
    J Thromb Haemost; 2015 Jan; 13(1):2-9. PubMed ID: 25393788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Status and Prevalent Early Age-Related Macular Degeneration in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study.
    Millen AE; Nie J; Sahli MW; Mares JA; Meyers KJ; Klein BEK; LaMonte MJ; Lutsey PL; Andrews CA; Klein R
    J Nutr Health Aging; 2017; 21(7):772-780. PubMed ID: 28717807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans.
    Folsom AR; Tang W; Weng LC; Roetker NS; Cushman M; Basu S; Pankow JS
    J Thromb Haemost; 2016 Jan; 14(1):83-8. PubMed ID: 26565658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Folsom AR; Tang W; Roetker NS; Heckbert SR; Cushman M; Pankow JS
    Am J Hematol; 2015 Nov; 90(11):1047-51. PubMed ID: 26260105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.
    El Khoudary SR; Samargandy S; Zeb I; Foster T; de Boer IH; Li D; Budoff MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):114-122. PubMed ID: 31761548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.
    Alonso A; Misialek JR; Michos ED; Eckfeldt J; Selvin E; Soliman EZ; Chen LY; Gross MD; Lutsey PL
    Europace; 2016 Aug; 18(8):1143-9. PubMed ID: 26847078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D metabolites and bone mineral density: The multi-ethnic study of atherosclerosis.
    van Ballegooijen AJ; Robinson-Cohen C; Katz R; Criqui M; Budoff M; Li D; Siscovick D; Hoofnagle A; Shea SJ; Burke G; de Boer IH; Kestenbaum B
    Bone; 2015 Sep; 78():186-93. PubMed ID: 25976951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18,791 participants.
    Brøndum-Jacobsen P; Benn M; Tybjaerg-Hansen A; Nordestgaard BG
    J Thromb Haemost; 2013 Mar; 11(3):423-31. PubMed ID: 23279309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
    Reis JP; Michos ED; Selvin E; Pankow JS; Lutsey PL
    Am J Clin Nutr; 2015 Jun; 101(6):1232-40. PubMed ID: 25926504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.
    Tsai AW; Cushman M; Rosamond WD; Heckbert SR; Polak JF; Folsom AR
    Arch Intern Med; 2002 May; 162(10):1182-9. PubMed ID: 12020191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort.
    Folsom AR; Lutsey PL; Astor BC; Cushman M
    Thromb Haemost; 2009 Oct; 102(4):615-9. PubMed ID: 19806245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.